Sign Up Today and Learn More About Neurent Medical Stock
Invest in or calculate the value of your shares in Neurent Medical or other pre-IPO companies through EquityZen's platform.
Neurent Medical Stock
Neurent Medical is a medical device startup that develops non-surgical treatments for inflammatory sino-nasal diseases.
About Neurent Medical Stock
Founded
2014
Industries
Software, Artificial Intelligence, Data and Analytics
Neurent Medical Press Mentions
Stay in the know about the latest news on Neurent Medical
Neurent Medical raises €62.5M Series C to expand Chronic Rhinitis Treatment
founderstoday • Feb 14, 2026
Financings for Feb. 13, 2026
bioworld • Feb 14, 2026
Chronic rhinitis solution NEUROMARK secures €62.5 million as Irish startup Neurent Medical closes Series C
eu-startups • Feb 13, 2026
Neurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic Rhinitis
biospace • Feb 12, 2026
Neurent secures $74m to expand NEUROMARK commercial activities
medicaldevice-network • Feb 12, 2026
Neurent Medical Management
Leadership team at Neurent Medical
CTO & Co-Founder
David Townley
CEO & Co-Founder
Brian Shields
Join now and verify your accreditation status to gain access to:
- Neurent Medical Current Valuation
- Neurent Medical Stock Price
- Neurent Medical Management
- Available deals in Neurent Medical and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Neurent Medical Cap Table and Funding History by Share Class and Liquidity Preferences
- Neurent Medical Revenue and Financials
- Neurent Medical Highlights
- Neurent Medical Business Model
- Neurent Medical Risk Factors
- Neurent Medical Research Report from SACRA Research
Trading Neurent Medical Stock
How to invest in Neurent Medical stock?
Accredited investors can buy pre-IPO stock in companies like Neurent Medical through EquityZen funds. These investments are made available by existing Neurent Medical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Neurent Medical stock?
Shareholders can sell their Neurent Medical stock through EquityZen's private company marketplace. EquityZen's network includes over 420K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."